MARKET

PBE

PBE

Invesco Biotechnology & Genome ETF
NYSEARCA
68.39
+0.16
+0.23%
After Hours: 68.00 -0.39 -0.57% 16:04 07/15 EDT
OPEN
68.29
PREV CLOSE
68.24
HIGH
68.80
LOW
68.29
VOLUME
5.45K
TURNOVER
0
52 WEEK HIGH
68.80
52 WEEK LOW
52.44
TOTAL ASSET
270.97M
YTD YIELD
10.54%
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PBE last week (0708-0712)?
Weekly Report · 14h ago
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
NASDAQ · 3d ago
Weekly Report: what happened at PBE last week (0701-0705)?
Weekly Report · 07/08 09:47
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
Midyear Equity Outlook - Investing Beyond The Megacaps
Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.
Seeking Alpha · 07/03 12:00
Weekly Report: what happened at PBE last week (0624-0628)?
Weekly Report · 07/01 09:47
From AI To Green Metals: Strategic Investments For A Changing World
Green transition is driving this unprecedented demand for metals and minerals. By 2030, we will need 50 new lithium mines to meet the growing demand for electric vehicles (EVs) and renewable energy infrastructure. The clean appearance of EVs, solar panels, and windmills belies the dirty reality that they require lots and lots of mining.
Seeking Alpha · 06/27 01:15
Invesco Dynamic Biotechnology & Genome ETF declares quarterly distribution of $0.0082
Seeking Alpha · 06/25 14:49
More
Profile
Fund Name
Invesco Biotechnology & Genome ETF
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco Capital Management LLC
Custodian
Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi